|
|
| |
Neurodevices: A Leading Medical Market
 NDI is focused on investing in and developing products in the neurodevices sector, which consists of medical devices, stimulators, surgical equipment and software to treat illnesses of the brain and nervous system.
This sector has consistently outperformed other common areas of investment as measured by Total Shareholder Return:
- Within the $220 billion medical device market, the neurodevice segment is one of the most exciting growth areas, with an annual growth rate of 18.6% according to NeuroInsights.
The worldwide market for neurodevices is now more than $6 billion per year, with significant growth projected over the next decade due to increases in age-related and treatment-resistant neurological diseases and disorders, and driven by the critical need for effective neurodevices to treat them.
- FDA-approved neurodevices are currently used to treat a wide variety of indications, including chronic pain, hearing loss, Parkinson’s disease and urinary incontinence.
Within the next decade, the neurodevice sector is expected to rival the $18 billion cardiac market, as new markets proliferate, especially in those areas where drug therapies are ineffective, such as in:
- Stroke and treatment-resistant patients suffering from a wide range of disorders including pain, depression, epilepsy and obesity.
|
|
|